School of Medicine
Showing 11-20 of 125 Results
-
Jehan Bahrainwala, MD, FASN
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Bahrainwala is a board-certified, fellowship-trained nephrologist with the Stanford Medicine Kidney Clinic at Boswell. She is a part of the AHA-Certified Stanford Hypertension Center. One of her main clinical areas of focus is the diagnosis and treatment of resistant hypertension and secondary hypertension. She also has a clinical interest in caring for patients who are pregnant or planning pregnancy with hypertension and kidney disease. In addition to hypertension, she also cares for patients with all types of kidney diseases. Her extensive experience includes caring for patients with electrolyte abnormalities, kidney stones, chronic kidney disease and end stage kidney disease.
Dr. Bahrainwala is skilled at creating connections with her patients. She treats the whole person rather than the condition. She also strongly believes in patient education and involving them in the medical decision-making process. She integrates their goals of care and other aspects of advanced care planning into treatment planning. She is also interested in the conservative care of elderly patients with advanced kidney disease. She has formal communication skills training in discussing serious illnesses with patients through Vital Talk.
In addition to being a clinician, she is committed to and involved in the medical education of trainees at all levels including medical students, residents and fellows. She is a fellow and a member of the American Society of Nephrology. Additionally, she is a member of the National Kidney Foundation and the American Heart Association. She is double board certified in internal medicine and nephrology. -
Xiangqi Bai
Postdoctoral Scholar, Oncology
BioMy research is focused on computational and systems biology. My primary research interest lies in developing new computational algorithms and statistical methods for the analysis of complex data in biological systems, especially related to the large-scale single-cell RNA sequencing data. The specific topics I have examined include:
1. Integration of single-cell multi-omics datasets for tumor
2. Statistical test of cell developmental trajectories
3. Visualization and reconstruction of single-cell RNA sequencing data
4. Computational analysis of the bifurcating event revealed by dynamical network biomarker methods -
Michael Baiocchi
Associate Professor of Epidemiology and Population Health and, by courtesy, of Statistics and of Medicine (Stanford Prevention Research Center)
BioProfessor Baiocchi is a PhD statistician in Stanford University's Epidemiology and Population Health Department. He thinks a lot about behavioral interventions and how to rigorously evaluate if and how they work. Methodologically, his work focuses on creating statistically rigorous methods for causal inference that are transparent and easy to critique. He designed -- and was the principle investigator for -- two large randomized studies of interventions to prevent sexual assault in the settlements of Nairobi, Kenya.
Professor Baiocchi is an interventional statistician (i.e., grounded in both the creation and evaluation of interventions). The unifying idea in his research is that he brings rigorous, quantitative approaches to bear upon messy, real-world questions to better people's lives. -
Matthew C. Baker, MD MS
Assistant Professor of Medicine (Immunology and Rheumatology)
BioDr. Baker is the Associate Division Chief in the Division of Immunology and Rheumatology at Stanford University and the Co-Founder and Co-Director of the Stanford Multidisciplinary Sarcoidosis Program. He received his bachelor's degree from Pomona College, his medical degree from Harvard Medical School, and his master's degree in Epidemiology and Clinical Research from Stanford University. He completed his Internal Medicine residency at the Massachusetts General Hospital and his Rheumatology fellowship at Stanford University. Dr. Baker has established a clinical research program that is focused on clinical trials, epidemiological studies, and bench-to-bedside translational research. He has designed and led investigator-initiated and industry sponsored clinical trials with a focus on sarcoidosis, IgG4-related disease, Sjogren's syndrome, and rheumatoid arthritis. He also utilizes large databases to study osteoarthritis, with an interest in repurposing existing drugs for the treatment of osteoarthritis.
